ArticleFrontiers in pharmacology2025
Building trust in clinical research: a systems approach to ethical engagement and sustainable outcomes.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Ethics as if Your Life Depended on It.Journal of empirical research on human research ethics : JERHRE · 2026Article
- Responses to Commentaries on "Ethics as if Your Life Depended on It".Journal of empirical research on human research ethics : JERHRE · 2026Article
- Patient-reported outcomes in masculinizing gender-affirming chest surgery: validation of the GENDER-Q Chest scales.The British journal of surgery · 2026Article
- Understanding public perspectives of prehospital trauma research: A qualitative community engagement study on consent and blood transfusion.Transfusion · 2026Article
- Exercise as a Programmable Regulator of Mitophagy Sensitivity in Aging Muscle and Age-Related Disease.IUBMB life · 2026Review
- From evidence to practice: factors influencing the implementation of cord blood treatment for cerebral palsy in the United States.Stem cells translational medicine · 2026Article
- Embedded transparency in artificial intelligence: a prerequisite for equity and representation in AI-enabled clinical trials.NPJ digital medicine · 2026Article
- Barriers and opportunities for clinical trials in Bahrain: a qualitative study of key opinion leaders.BMJ open · 2026Article
- CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.The oncologist · 2026Article
- Rethinking child safety in community-based health programmes: A critical response to parents' perceptions of health coordinators.Public health in practice (Oxford, England) · 2026Article
- Embedding equity in clinical research governance.Nature medicine · 2026Article
- Balancing altruism, risk and ethics: Vietnamese students' views on human challenge studies.PloS one · 2026Article
- Development of a Patient Journey Map for Metabolic Dysfunction-Associated Steatohepatitis: A Comprehensive Assessment of the Patient Journey in North America.Journal of patient experience · 2026Article
- Knowledge Translation Initiative to Improve Interdisciplinary Approaches to Psychosocial Oncology Among Community Stakeholders in Rural Regions of British Columbia.International journal of environmental research and public health · 2025Article
- Cooking for disability: a pilot study on nutritional interventions for mental health support in adults with autism spectrum disorder.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trust and trustworthiness are critical to the success of clinical research, profoundly influencing participant engagement, data integrity, and study outcomes. These behaviors emerge from complex, dynamic interactions within the clinical research ecosystem, involving stakeholders such as sponsors, participants, clinicians, researchers, and regulatory bodies. The rapid development of COVID-19 vaccines has underscored the potential of scientific advancements to build public trust in the scientific outcomes, while also exposing vulnerabilities in the procedural trust framework due to misinformation and historical unethical practices. This paper explores trust and trustworthiness as emergent properties within the complex systems of clinical research, highlighting their evolution through transparent communication, participant empowerment, and ethical governance. A systems approach is emphasized, where trust develops holistically, influenced by regulatory frameworks, interpersonal relationships, and the overall research environment. Practical implications include the adoption of adaptive consent models, interdisciplinary collaboration, and the integration of continuous feedback mechanisms. To address trust erosion, especially among marginalized communities, we advocate for participatory research approaches and the development of new professional competencies, such as the role of a Clinical Research Liaison. This role would ensure ongoing alignment with community needs, enhance transparency, and maintain ethical standards, ultimately fostering a research environment where trust and trustworthiness thrive, benefiting both participants and the broader scientific community. A roadmap for future efforts includes the systematic incorporation of these elements into clinical research practices to enhance trust and improve research outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.